Search

Your search keyword '"Zhang, Yuhu"' showing total 109 results

Search Constraints

Start Over You searched for: Author "Zhang, Yuhu" Remove constraint Author: "Zhang, Yuhu" Database MEDLINE Remove constraint Database: MEDLINE
109 results on '"Zhang, Yuhu"'

Search Results

1. High-temperature 205 Tl decay clarifies 205 Pb dating in early Solar System.

2. Levodopa therapy affects brain functional network dynamics in Parkinson's disease.

3. Cenococcum geophilum impedes cadmium toxicity in Pinus massoniana by modulating nitrogen metabolism.

4. Early identification of stroke through deep learning with multi-modal human speech and movement data.

5. Temporal evolution of microstructural integrity in cerebellar peduncles in Parkinson's disease: Stage-specific patterns and dopaminergic correlates.

6. Life course and mental health: a thematic and systematic review.

7. Plasma sphingolipids, dopaminergic degeneration and clinical progression in idiopathic Parkinson's disease.

8. Motor progression trajectories and risk of mild cognitive impairment in Parkinson's disease: A latent class trajectory model from PPMI cohort.

9. Interocular asymmetry of retinal change in Parkinson's disease.

10. Soot nanoparticles promote ferroptosis in dopaminergic neurons via alteration of m6A RNA methylation in Parkinson's disease.

11. Brain network centrality and connectivity are associated with clinical subtypes and disease progression in Parkinson's disease.

12. Fe 3 O 4 /biochar modified with molecularly imprinted polymer as efficient persulfate activator for salicylic acid removal from wastewater: Performance and specific recognition mechanism.

13. TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson's Disease Mice and LPS-Induced BV2 Cells.

14. The association of CSF biomarkers and cognitive decline with choroid plexus volume in early Parkinson's disease.

15. A review of the neurotransmitter system associated with cognitive function of the cerebellum in Parkinson's disease.

16. Structural Network Efficiency Predicts Conversion to Incident Parkinsonism in Patients With Cerebral Small Vessel Disease.

17. Convergent and divergent intra- and internetwork connectivity in Parkinson's disease with wearing-off.

18. Voxel-based morphometry of grey matter structures in Parkinson's Disease with wearing-off.

19. The Ectomycorrhizal Fungi and Soil Bacterial Communities of the Five Typical Tree Species in the Junzifeng National Nature Reserve, Southeast China.

20. Associations between insomnia and large vessel occlusion acute ischemic stroke: An observational study.

21. Decrease of Cellular Communication Network Factor 1 (CCN1) Attenuates PTZ-Kindled Epilepsy in Mice.

22. Novel heterozygous VPS13A pathogenic variants in chorea-neuroacanthocytosis: a case report.

23. The Association of the Glymphatic Function with Parkinson's Disease Symptoms: Neuroimaging Evidence from Longitudinal and Cross-Sectional Studies.

24. Motor progression phenotypes in early-stage Parkinson's Disease: A clinical prediction model and the role of glymphatic system imaging biomarkers.

25. Increased Tolerance of Massion's pine to Multiple-Toxic-Metal Stress Mediated by Ectomycorrhizal Fungi.

26. Cerebral Microvascular Injury Induced by Lag3-Dependent α-Synuclein Fibril Endocytosis Exacerbates Cognitive Impairment in a Mouse Model of α-Synucleinopathies.

27. Myo1d promotes alpha-synuclein transfer from brain microvascular endothelial cells to pericytes through tunneling nanotubes.

28. Neuronavigated repetitive transcranial magnetic stimulation improves depression, anxiety and motor symptoms in Parkinson's disease.

29. Homogeneous-resolution photoacoustic microscopy for ultrawide field-of-view neurovascular imaging in Alzheimer's disease.

30. Cortical connectivity of cholinergic basal forebrain in Parkinson's disease with mild cognitive impairment.

31. Abnormal cerebellum connectivity patterns related to motor subtypes of Parkinson's disease.

32. MAPKAPK2, a potential dynamic network biomarker of α-synuclein prior to its aggregation in PD patients.

33. Endothelial LRP1-ICD Accelerates Cognition-Associated Alpha-Synuclein Pathology and Neurodegeneration through PARP1 Activation in a Mouse Model of Parkinson's Disease.

34. Diffusion along perivascular spaces provides evidence interlinking compromised glymphatic function with aging in Parkinson's disease.

35. Lipid storage myopathy due to late-onset multiple Acyl-CoA dehydrogenase deficiency with novel mutations in ETFDH: A case report.

36. Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI dataset.

37. Measurement of 19 F(p, γ) 20 Ne reaction suggests CNO breakout in first stars.

38. An integrated technical, economic, and environmental framework for evaluating the rooftop photovoltaic potential of old residential buildings.

39. Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders.

40. Metabolite changes in prefrontal lobes and the anterior cingulate cortex correlate with processing speed and executive function in Parkinson disease patients.

41. Distinct Bile Acid Signature in Parkinson's Disease With Mild Cognitive Impairment.

42. Identifying Depression in Parkinson's Disease by Using Combined Diffusion Tensor Imaging and Support Vector Machine.

43. TGR5 Agonist INT-777 Alleviates Inflammatory Neurodegeneration in Parkinson's Disease Mouse Model by Modulating Mitochondrial Dynamics in Microglia.

44. Retinal microvascular impairment in Parkinson's disease with cognitive dysfunction.

46. Identifying Parkinson's disease with mild cognitive impairment by using combined MR imaging and electroencephalogram.

47. Abnormal Neural Activity in Different Frequency Bands in Parkinson's Disease With Mild Cognitive Impairment.

48. Significant Difference of Immune Cell Fractions and Their Correlations With Differential Expression Genes in Parkinson's Disease.

49. Serum Folate, Vitamin B12 Levels, and Systemic Immune-Inflammation Index Correlate With Motor Performance in Parkinson's Disease: A Cross-Sectional Study.

50. Non-pharmacological treatment for Parkinson disease patients with depression: a meta-analysis of repetitive transcranial magnetic stimulation and cognitive-behavioral treatment.

Catalog

Books, media, physical & digital resources